NCT01200862View on ClinicalTrials.gov

Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men

PHASE2TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Obese Hypogonadotropic Hypogonadism
Interventions
DRUG

Investigational new drug company code: BGS649

DRUG

Placebo

Trial Locations (5)

33025

Novartis Investigative Site, Miramar

84120

Novartis Investigative Site, West Valley City

85712

Novartis Investigative Site, Tucson

92120

Novartis Investigative Site, San Diego

H3X 2H9

Novartis Investigative Site, Montreal

Sponsors

Lead Sponsor

Mereo BioPharma

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Mereo BioPharma

INDUSTRY